2015 American Transplant Congress
Improving the Predictive Value of the Virtual Crossmatch: Is the C1Q Assay Needed?
The criteria for reporting unacceptable HLA antigens of renal transplant candidates differ greatly between transplant centers. In the attempt to refine these criteria, the experience…2015 American Transplant Congress
The Association of Basiliximab and Antithymocyte Globulin Induction With Delayed Graft Function
The impact of selection of induction immunosuppression agent on incidence of delayed graft function (DGF) remains unclear. A total of 1,980 deceased donor kidney transplant…2015 American Transplant Congress
Influence of Cold Ischemia Time in Combination With Donor Ischemic Events on Kidney Transplant Outcomes
Transplantation, Montefiore Medical Center, Bronx, NY.
Deceased-donor kidneys may be exposed to various ischemic events either from donor instability as evidenced by acute kidney injury (AKI) or donation after circulatory death…2015 American Transplant Congress
Risks for Readmission Post-Renal Transplant: A Co-Morbid Condition
Transplant Institute, Tulane University, New Orleans, LA.
Background: Recently CMS addressed “excessive” readmission rates with a punitive 5% cut in reimbursement. For decades renal transplantation has been highly regulated with published outcomes…2015 American Transplant Congress
Infectious Complications in ABO Incompatible Kidney Transplantation Recipient According to the Rituximab Dose
BackgroundDesensitization with rituximab and intravenous immunoglobulin improves ABO incompatible (ABOi) kidney transplantation (KT) outcomes. However, infections have been noted in association with rituximab administration. In…2015 American Transplant Congress
Age Should Not Be Considered a Contraindication for Living Kidney Donation
Imperial College Renal and Transplant Centre, Hammersmith Hospital, London, United Kingdom.
The increasing numbers of patients with ESRD on the transplant waiting list has been the main driving force for expanding the donor pool. Acceptance of…2015 American Transplant Congress
The Potential of E-Health to Improve Adherence: Exploring the Patients' View
Introduction. Transplant outcomes can be negatively influenced by medication nonadherence. Therefore, there is a need for effective interventions to improve adherence. In recent years due…2015 American Transplant Congress
Vaccine Responses in Combined Hematopoeitic Stem Cell-Kidney Transplant Recipients
Background: Vaccines remain one of the most effective methods of preventing infections following transplantation. Data suggests that vaccine responses are reduced in recipients of hematopoeitic…2015 American Transplant Congress
Operational Tolerance in Kidney Transplantation: Results of a Europe-Wide Survey
BACKGROUND: Operational Tolerance (opTOL) is deemed to be extremely rare in kidney transplantation. We launched a Europe-wide survey to assess the frequency of opTOL.METHODS: 18…2015 American Transplant Congress
Outcomes of Post-Kidney Transplant Leukemias
Medicine, University of Minnesota, Minneapolis, MN.
Background:Leukemias typically portend bad prognosis in the general population. The incidence and outcomes of post-kidney transplant leukemias (PKTL) have not been well studied as most…
- « Previous Page
- 1
- …
- 486
- 487
- 488
- 489
- 490
- …
- 531
- Next Page »